This resource is no longer available
Lunit, a Korean tech company, is transforming cancer detection and treatment through AI technology. Their software facilitates early-stage cancer diagnosis, enhancing survival rates by up to 4.3 times for lung cancer.
Lunit is committed to making this tech accessible and affordable by offering flexible subscription-based pricing.
To address challenges related to compliance and intellectual property protection, Lunit implemented a robust software licensing system from Thales, enabling them to scale their operations effectively.
Gaining global recognition, Lunit has been selected by the WHO as the exclusive AI software provider for tuberculosis screening.
Read the case study to learn more about their journey.
- Vendor:
- Thales
- Posted:
- Sep 26, 2024
- Published:
- Sep 27, 2024
- Format:
- Type:
- Case Study
